WCG Clinical

Clinical research services and technology company (IRB review, site solutions) with AI-driven trial planning via ClinSphere Trial IntelX.

WCG, headquartered in Princeton, New Jersey, traces its roots to the Western Institutional Review Board founded in 1968 and is a private equity-owned provider of ethical review (IRB/IBC), site enablement, and clinical trial intelligence. In January 2026 it launched ClinSphere Trial IntelX, an AI product that predicts how protocol design choices affect trial performance before first participant in. WCG sold its eCOA business to Clario, so its center of gravity is review services, site solutions, and trial planning rather than data capture. Atlas found no vendor-held security certifications documented on its site.

Headquarters
Princeton, United States
Founded
1968
Deployment options
cloud
Website
https://www.wcgclinical.com

Categories

AI Use Cases

  • Protocol Design Optimization
  • Site Selection & Performance

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents WCG Clinical across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Academic / Research, Clinical Operations, R&D Leadership

Solution Scope — Documented

Trial Protocol Optimization

Company Viability — Partially documented

Private equity, Founded 1968

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • What historical data trains Trial IntelX predictions, and how is accuracy measured?
  • How do review services and technology products connect for our study portfolio?
  • What turnaround times are typical for IRB review at our volume?
  • Which outputs from Trial IntelX can be used directly in protocol development?